江泉實業(600212.SH)實控人變更為徐益明 控股股東變更為景宏益誠
格隆匯11月22日丨江泉實業(600212.SH)公佈,2019年11月22日,公司收到深圳景宏益誠實業發展有限公司(以下簡稱“景宏益誠”)轉交的由中國證券登記結算有限責任公司出具的《過户登記確認書》。景宏益誠通過深圳市中級人民法院司法拍賣途徑競得的公司6566.707萬股股份,已於2019年11月22日通過中國證券登記結算有限責任公司辦理完畢過户登記手續。
本次股份過户完成後,景宏益誠持有公司股份6566.707萬股(股份性質為無限售流通股),佔公司總股本的比例為12.83%,成為公司控股股東,徐益明成為公司實際控制人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.